A Trial-Based Approach to Statin Guidelines

被引：42

作者：

Ridker, Paul M. ^{[1
]}

Wilson, Peter W. F. ^{[2
,3
]}

机构：

[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA

[2] Emory Clin Cardiovasc Res Inst, Atlanta, GA USA

[3] Atlanta Vet Adm Med Ctr, Atlanta, GA USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2013年 / 310卷 / 11期

关键词：

THERAPY; RISK; CHOLESTEROL;

D O I：

10.1001/jama.2013.276529

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1123 / 1124

页数：2

共 7 条

[1] Refocusing the Agenda on Cardiovascular Guidelines An Announcement From the National Heart, Lung, and Blood Institute
Gibbons, Gary H.
Shurin, Susan B.
Mensah, George A.
Lauer, Michael S.
[J]. CIRCULATION, 2013, 128 (15) : 1713 - 1715
[2] Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
Grundy, SM
Cleeman, JI
Merz, CNB
Brewer, HB
Clark, LT
Hunninghake, DB
Pasternak, RC
Smith, SC
Stone, NJ
[J]. CIRCULATION, 2004, 110 (02) : 227 - 239
[3] Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278
[4] The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
Mihaylova, B.
Emberson, J.
Blackwell, L.
Keech, A.
Simes, J.
Barnes, E. H.
Voysey, M.
Gray, A.
Collins, R.
Baigent, C.
de Lemos, J.
Braunwald, E.
Blazing, M.
Murphy, S.
Downs, J. R.
Gotto, A.
Clearfield, M.
Holdaas, H.
Gordon, D.
Davis, B.
Koren, M.
Dahlof, B.
Poulter, N.
Sever, P.
Knopp, R. H.
Fellstrom, B.
Holdaas, H.
Jardine, A.
Schmieder, R.
Zannad, F.
Goldbourt, U.
Kaplinsky, E.
Colhoun, H. M.
Betteridge, D. J.
Durrington, P. N.
Hitman, G. A.
Fuller, J.
Neil, A.
Wanner, C.
Krane, V.
Sacks, F.
Moye, L.
Pfeffer, M.
Hawkins, C. M.
Braunwald, E.
Kjekshus, J.
Wedel, H.
Wikstrand, J.
Barter, P.
Keech, A.
[J]. LANCET, 2012, 380 (9841) : 581 - 590
[5] Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysis
Preiss, David
Seshasai, Sreenivasa Rao Kondapally
Welsh, Paul
Murphy, Sabina A.
Ho, Jennifer E.
Waters, David D.
DeMicco, David A.
Barter, Philip
Cannon, Christopher P.
Sabatine, Marc S.
Braunwald, Eugene
Kastelein, John J. P.
de Lemos, James A.
Blazing, Michael A.
Pedersen, Terje R.
Tikkanen, Matti J.
Sattar, Naveed
Ray, Kausik K.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (24): : 2556 - 2564
[6] Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis
Rajpathak, Swapnil N.
Kumbhani, Dharam J.
Crandall, Jill
Barzilai, Nir
Alderman, Michael
Ridker, Paul M.
[J]. DIABETES CARE, 2009, 32 (10) : 1924 - 1929
[7] What Works and in Whom? A Simple, Easily Applied, Evidence-Based Approach to Guidelines for Statin Therapy
Ridker, Paul M.
[J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2012, 5 (04): : 592 - 593

← 1 →